Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment

Yao Lin Kao; Jian Ting Chen; Sung Lang Chen; I. Hung Shao; Chung Cheng Wang; I. Ni Chiang; Yu Chao Hsu; Kau Han Lee; Wei Chia Lee; Ting Chun Yeh; Yuh Chen Kuo; Bing Juin Chiang; Chun Hou Liao; Po Cheng Chen; En Meng; Yung Chin Lee; Hann Chorng Kuo

doi:10.4103/UROS.UROS_116_22

Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment

Yao Lin Kao, Jian Ting Chen, Sung Lang Chen, I. Hung Shao, Chung Cheng Wang, I. Ni Chiang, Yu Chao Hsu, Kau Han Lee, Wei Chia Lee, Ting Chun Yeh, Yuh Chen Kuo, Bing Juin Chiang, Chun Hou Liao, Po Cheng Chen, En Meng, Yung Chin Lee, Hann Chorng Kuo

Department of Urology(NCKUH)

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Bladder management of chronic spinal cord injured (SCI) patients usually starts with conservative treatment or minimally invasive procedures. This article reports the current evidence and expert opinions on the patient-centered bladder management of neurogenic lower urinary tract dysfunction (NLUTD) among patients with chronic SCI in Taiwan. We evaluated the role of clean intermittent catheterization (CIC), cystostomy, medical treatment, and minimally invasive therapy for treating urinary incontinence and voiding dysfunction in patients with chronic SCI. The bladder management for chronic SCI patients should be individualized. A balance between upper urinary tract protection and life quality improvement should be considered. Hand dexterity, abdominal muscle power, bladder sensation, and degree of urethral sphincter dyssynergia might affect the improvement of voiding efficiency and NLUTD. Intradetrusor Botulinum Toxin Type A (BoNT-A) injection has been proven to effectively treat neurogenic detrusor overactivity in SCI patients. However, CIC is still required in some patients after treatment. The urethral sphincter BoNT-ABoNT-A injection can effectively relax the dyssynergic sphincter; however, exacerbation of urinary incontinence usually limits its application in SCI patients. Repeat BoNT-ABoNT-A injection is necessary to maintain the therapeutic efficacy; therefore, some SCI patients might discontinue the treatment and convert to a permanent bladder management by surgical intervention. Identification of high-risk SCI patients is important to prevent renal functional deterioration in those with chronic SCI-NLUTD. Avoiding renal function deterioration and improving the quality of life of SCI patients with NLUTD are the most important aspects of treatment. Annual active surveillance of bladder and renal function is necessary.

Original language	English
Pages (from-to)	10-17
Number of pages	8
Journal	Urological Science
Volume	34
Issue number	1
DOIs	https://doi.org/10.4103/UROS.UROS_116_22
Publication status	Published - 2023 Jan

All Science Journal Classification (ASJC) codes

Urology

Access to Document

10.4103/UROS.UROS_116_22

Cite this

Kao, Y. L., Chen, J. T., Chen, S. L., Shao, I. H., Wang, C. C., Chiang, I. N., Hsu, Y. C., Lee, K. H., Lee, W. C., Yeh, T. C., Kuo, Y. C., Chiang, B. J., Liao, C. H., Chen, P. C., Meng, E., Lee, Y. C., & Kuo, H. C. (2023). Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment. Urological Science, 34(1), 10-17. https://doi.org/10.4103/UROS.UROS_116_22

@article{547b74e92c7e445798f9d5a607b4cd00,

title = "Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment",

abstract = "Bladder management of chronic spinal cord injured (SCI) patients usually starts with conservative treatment or minimally invasive procedures. This article reports the current evidence and expert opinions on the patient-centered bladder management of neurogenic lower urinary tract dysfunction (NLUTD) among patients with chronic SCI in Taiwan. We evaluated the role of clean intermittent catheterization (CIC), cystostomy, medical treatment, and minimally invasive therapy for treating urinary incontinence and voiding dysfunction in patients with chronic SCI. The bladder management for chronic SCI patients should be individualized. A balance between upper urinary tract protection and life quality improvement should be considered. Hand dexterity, abdominal muscle power, bladder sensation, and degree of urethral sphincter dyssynergia might affect the improvement of voiding efficiency and NLUTD. Intradetrusor Botulinum Toxin Type A (BoNT-A) injection has been proven to effectively treat neurogenic detrusor overactivity in SCI patients. However, CIC is still required in some patients after treatment. The urethral sphincter BoNT-ABoNT-A injection can effectively relax the dyssynergic sphincter; however, exacerbation of urinary incontinence usually limits its application in SCI patients. Repeat BoNT-ABoNT-A injection is necessary to maintain the therapeutic efficacy; therefore, some SCI patients might discontinue the treatment and convert to a permanent bladder management by surgical intervention. Identification of high-risk SCI patients is important to prevent renal functional deterioration in those with chronic SCI-NLUTD. Avoiding renal function deterioration and improving the quality of life of SCI patients with NLUTD are the most important aspects of treatment. Annual active surveillance of bladder and renal function is necessary.",

author = "Kao, {Yao Lin} and Chen, {Jian Ting} and Chen, {Sung Lang} and Shao, {I. Hung} and Wang, {Chung Cheng} and Chiang, {I. Ni} and Hsu, {Yu Chao} and Lee, {Kau Han} and Lee, {Wei Chia} and Yeh, {Ting Chun} and Kuo, {Yuh Chen} and Chiang, {Bing Juin} and Liao, {Chun Hou} and Chen, {Po Cheng} and En Meng and Lee, {Yung Chin} and Kuo, {Hann Chorng}",

year = "2023",

month = jan,

doi = "10.4103/UROS.UROS_116_22",

language = "English",

volume = "34",

pages = "10--17",

journal = "Urological Science",

issn = "1879-5226",

publisher = "Elsevier",

number = "1",

}

Kao, YL, Chen, JT, Chen, SL, Shao, IH, Wang, CC, Chiang, IN, Hsu, YC, Lee, KH, Lee, WC, Yeh, TC, Kuo, YC, Chiang, BJ, Liao, CH, Chen, PC, Meng, E, Lee, YC & Kuo, HC 2023, 'Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment', Urological Science, vol. 34, no. 1, pp. 10-17. https://doi.org/10.4103/UROS.UROS_116_22

Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment. / Kao, Yao Lin; Chen, Jian Ting; Chen, Sung Lang et al.
In: Urological Science, Vol. 34, No. 1, 01.2023, p. 10-17.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2

T2 - Conservative and minimally invasive treatment

AU - Kao, Yao Lin

AU - Chen, Jian Ting

AU - Chen, Sung Lang

AU - Shao, I. Hung

AU - Wang, Chung Cheng

AU - Chiang, I. Ni

AU - Hsu, Yu Chao

AU - Lee, Kau Han

AU - Lee, Wei Chia

AU - Yeh, Ting Chun

AU - Kuo, Yuh Chen

AU - Chiang, Bing Juin

AU - Liao, Chun Hou

AU - Chen, Po Cheng

AU - Meng, En

AU - Lee, Yung Chin

AU - Kuo, Hann Chorng

PY - 2023/1

Y1 - 2023/1

N2 - Bladder management of chronic spinal cord injured (SCI) patients usually starts with conservative treatment or minimally invasive procedures. This article reports the current evidence and expert opinions on the patient-centered bladder management of neurogenic lower urinary tract dysfunction (NLUTD) among patients with chronic SCI in Taiwan. We evaluated the role of clean intermittent catheterization (CIC), cystostomy, medical treatment, and minimally invasive therapy for treating urinary incontinence and voiding dysfunction in patients with chronic SCI. The bladder management for chronic SCI patients should be individualized. A balance between upper urinary tract protection and life quality improvement should be considered. Hand dexterity, abdominal muscle power, bladder sensation, and degree of urethral sphincter dyssynergia might affect the improvement of voiding efficiency and NLUTD. Intradetrusor Botulinum Toxin Type A (BoNT-A) injection has been proven to effectively treat neurogenic detrusor overactivity in SCI patients. However, CIC is still required in some patients after treatment. The urethral sphincter BoNT-ABoNT-A injection can effectively relax the dyssynergic sphincter; however, exacerbation of urinary incontinence usually limits its application in SCI patients. Repeat BoNT-ABoNT-A injection is necessary to maintain the therapeutic efficacy; therefore, some SCI patients might discontinue the treatment and convert to a permanent bladder management by surgical intervention. Identification of high-risk SCI patients is important to prevent renal functional deterioration in those with chronic SCI-NLUTD. Avoiding renal function deterioration and improving the quality of life of SCI patients with NLUTD are the most important aspects of treatment. Annual active surveillance of bladder and renal function is necessary.

AB - Bladder management of chronic spinal cord injured (SCI) patients usually starts with conservative treatment or minimally invasive procedures. This article reports the current evidence and expert opinions on the patient-centered bladder management of neurogenic lower urinary tract dysfunction (NLUTD) among patients with chronic SCI in Taiwan. We evaluated the role of clean intermittent catheterization (CIC), cystostomy, medical treatment, and minimally invasive therapy for treating urinary incontinence and voiding dysfunction in patients with chronic SCI. The bladder management for chronic SCI patients should be individualized. A balance between upper urinary tract protection and life quality improvement should be considered. Hand dexterity, abdominal muscle power, bladder sensation, and degree of urethral sphincter dyssynergia might affect the improvement of voiding efficiency and NLUTD. Intradetrusor Botulinum Toxin Type A (BoNT-A) injection has been proven to effectively treat neurogenic detrusor overactivity in SCI patients. However, CIC is still required in some patients after treatment. The urethral sphincter BoNT-ABoNT-A injection can effectively relax the dyssynergic sphincter; however, exacerbation of urinary incontinence usually limits its application in SCI patients. Repeat BoNT-ABoNT-A injection is necessary to maintain the therapeutic efficacy; therefore, some SCI patients might discontinue the treatment and convert to a permanent bladder management by surgical intervention. Identification of high-risk SCI patients is important to prevent renal functional deterioration in those with chronic SCI-NLUTD. Avoiding renal function deterioration and improving the quality of life of SCI patients with NLUTD are the most important aspects of treatment. Annual active surveillance of bladder and renal function is necessary.

UR - http://www.scopus.com/inward/record.url?scp=85151624777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85151624777&partnerID=8YFLogxK

U2 - 10.4103/UROS.UROS_116_22

DO - 10.4103/UROS.UROS_116_22

M3 - Review article

AN - SCOPUS:85151624777

SN - 1879-5226

VL - 34

SP - 10

EP - 17

JO - Urological Science

JF - Urological Science

IS - 1

ER -

Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this